Randomized, Double-blind, Placebo-controlled Study of the Effect of a Single Injection of SAR164877 (REGN475) on Reduction of Pain From Chronic Pancreatitis
Phase of Trial: Phase II
Latest Information Update: 24 May 2013
At a glance
- Drugs Fasinumab (Primary)
- Indications Abdominal pain
- Focus Therapeutic Use
- Sponsors Sanofi
- 17 Feb 2011 Status changed from active, no longer recruiting to suspended.
- 22 Nov 2010 Status changed from recruiting to active, no longer recruiting.
- 05 Nov 2010 There are 42 centres in the US currently recruiting patients, as reported by ClinicalTrials.gov.